None of the dose-response parameters showed a significant trend of risk association, with all P-trends >0.10.[ 14 ] A 10-year observational cohort study as well as a nested case–control study were conducted in patients with diabetes who are members of Kaiser Permanente Northern California (KPNC) health plan.
← all excerpts
Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study.
1
—
—